Resilient HIV Implementation Science With SGM Youths Using Evidence
Launched by UNIVERSITY OF MARYLAND, BALTIMORE · Apr 1, 2024
Trial Information
Current as of August 19, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The RISE clinical trial is studying a digital health program designed specifically for young men who have sex with men (SGM) to improve their health related to HIV. The program, called HMP, aims to help these young people start taking PrEP, a medication that can prevent HIV, and to reduce the amount of virus in their bodies if they are living with HIV. Participants will be divided into two groups: one will use the HMP program immediately, while the other will wait for a period before starting. The researchers want to see if those using HMP right away will have better health outcomes after 12 months.
To be eligible for this trial, you need to be a male between the ages of 15 and 24, have a smartphone, and have had sexual contact with another man in the past year. You also need to be receiving care or prevention services related to HIV. Participants can expect to engage with the HMP program, which will provide support and resources for managing their health. It's important to note that the trial is not yet recruiting participants, so you’ll need to wait for the official start of enrollment.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Male sex at birth
- • Age 15-24 years
- • Own an Android or iOS smartphone
- • Had receptive or insertive sex with another man in the past 12 months
- • Receiving care or prevention services at the CBSP-associated with the CRPS at the time of study.
- Exclusion Criteria:
- • Less than 15 years old
- • Greater than 24 years old
- • Inability or cognitively impaired to provide consent
- • Does not own an Android or iOS smartphone.
About University Of Maryland, Baltimore
The University of Maryland, Baltimore (UMB) is a leading academic institution dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, UMB leverages its extensive resources and expertise across various disciplines, including medicine, pharmacy, nursing, and social work, to contribute to groundbreaking discoveries and improve patient outcomes. Committed to ethical research practices and collaboration, UMB fosters an environment that promotes the translation of scientific knowledge into real-world applications, ultimately enhancing the well-being of diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported